# PACLITAXEL
> **ANDA216874** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2022-10-20
## Drug
- **FDA Application Number:** ANDA216874
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PACLITAXEL
- **Generic name:** PACLITAXEL
- **Active ingredients:** PACLITAXEL
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** ALEMBIC
- **Manufacturer:** BluePoint Laboratories
- **First approval:** 2022-10-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216874)
---
*AI Analytics · CC0 1.0*